Advancing the Pharmacodynamic (PD) Characterization of Novel Central Nervous System (CNS) Compounds in Clinical Drug Development: Validation & Implementation of a Novel CNS Test Battery Framework.

Time: 11:45 am
day: Day One Track B AM

Details:

  • Comparing pharmacodynamic effects of lorazepam, modafinil, and S-ketamine using NeuroCart vs NeuroKit 
  • Evaluating VR-based task completion and biomarker sensitivity using the Facial Emotion Recognition Task (FERT) 
  • Estimating effect ratios across platforms for scalable CNS biomarker assessment 
  • Highlighting NeuroKit’s potential for remote, high-quality CNS monitoring

Speakers: